Simple jQuery Dropdowns

Browsing by Author Udomsak Bunworasate

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
1-Jan-2020Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study GroupKitsada Wudhikarn; Udomsak Bunworasate; Jakrawadee Julamanee; Arnuparp Lekhakula; Supachai Ekwattanakit; Archrob Khuhapinant; Suporn Chuncharunee; Pimjai Niparuck; Tontanai Numbenjapon; Kannadit Prayongratana; Nonglak Kanitsap; Somchai Wongkhantee; Nisa Makruasi; Peerapon Wong; Lalita Norasetthada; Weerasak Nawarawong; Chittima Sirijerachai; Kanchana Chansung; Tawatchai Suwanban; Pannee Praditsuktavorn; Tanin Intragumtornchai; Chulalongkorn University; Naresuan University; Khon Kaen University; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Thammasat University; Faculty of Medicine, Siriraj Hospital, Mahidol University; Phramongkutklao College of Medicine; Prince of Songkla University; Rajavithi Hospital; Chiang Mai University; Srinakharinwirot University; Khonkaen Regional Hospital; Chulabhorn Hospital
7-Feb-2013Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation programRosarin Sruamsiri; Nathorn Chaiyakunapruk; Samart Pakakasama; Somtawin Sirireung; Nintita Sripaiboonkij; Udomsak Bunworasate; Suradej Hongeng; Naresuan University; University of Queensland; University of Wisconsin Madison; Jeffrey Cheah School of Medicine and Health Sciences; Mahidol University; Chulalongkorn University
1-Dec-2019Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphomaKitsada Wudhikarn; Udomsak Bunworasate; Jakrawadee Julamanee; Arnuparp Lekhakula; Supachai Ekwattanakit; Archrob Khuhapinant; Pimjai Niparuck; Suporn Chuncharunee; Tontanai Numbenjapon; Kannadit Prayongratana; Nonglak Kanitsap; Somchai Wongkhantee; Nisa Makruasri; Peerapon Wong; Lalita Norasetthada; Weerasak Nawarawong; Chittima Sirijerachai; Kanchana Chansung; Tawatchai Suwanban; Pannee Praditsuktavorn; Tanin Intragumtornchai; Chulalongkorn University; Naresuan University; Khon Kaen University; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Thammasat University; Faculty of Medicine, Siriraj Hospital, Mahidol University; Phramongkutklao College of Medicine; Prince of Songkla University; Rajavithi Hospital; Chiang Mai University; Srinakharinwirot University; Khonkaen Regional Hospital; Chulabhorn Hospital
1-Jan-2020Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study GroupKitsada Wudhikarn; Udomsak Bunworasate; Jakrawadee Julamanee; Arnuparp Lekhakula; Supachai Ekwattanakit; Archrob Khuhapinant; Pimjai Niparuck; Suporn Chuncharunee; Tontanai Numbenjapon; Kannadit Prayongratana; Nonglak Kanitsap; Somchai Wongkhantee; Nisa Makruasi; Peerapon Wong; Lalita Norasetthada; Weerasak Nawarawong; Chittima Sirijerachai; Kanchana Chansung; Tawatchai Suwanban; Pannee Praditsuktavorn; Tanin Intragumtornchai; Chulalongkorn University; Naresuan University; Khon Kaen University; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Thammasat University; Faculty of Medicine, Siriraj Hospital, Mahidol University; Phramongkutklao College of Medicine; Prince of Songkla University; Rajavithi Hospital; Chiang Mai University; Srinakharinwirot University; Khonkaen Regional Hospital; Chulabhorn Hospital
1-Apr-2012Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: A comprehensive clinicopathologic and phenotypic studyTawatchai Pongpruttipan; Sanya Sukpanichnant; Thamathorn Assanasen; Pongsak Wannakrairot; Paisarn Boonsakan; Wasana Kanoksil; Kanita Kayasut; Winyou Mitarnun; Archrob Khuhapinant; Udomsak Bunworasate; Teeraya Puavilai; Anan Bedavanija; Adriana Garcia-Herrera; Elias Campo; James R. Cook; John Choi; Steven H. Swerdlow; University of Pittsburgh; Mahidol University; Chulalongkorn University; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Prince of Songkla University; Universitat de Barcelona; Cleveland Clinic Foundation; University of Pennsylvania
1-Jan-2013Inferior progression-free survival for Thai patients with diffuse large B-cell lymphoma treated under Universal Coverage Scheme: the impact of rituximab inaccessabilityTanin Intragumtornchai; Udomsak Bunworasate; Noppadol Siritanaratkul; Archrob Khuhapinant; Weerasak Nawarawong; Lalita Norasetthada; Arnuparp Lekhakula; Pairaya Rujirojindakul; Chittima Sirijerachai; Kanjana Chansung; Tawatchai Suwanban; Suporn Chuncharunee; Pimjai Niparuck; Somchai Wongkhantee; Wichean Mongkonsritragoon; Tontanai Numbenjapon; Chulalongkorn University; Mahidol University; Chiang Mai University; Prince of Songkla University; Khon Kaen University; Rajavithi Hospital; Khon Kaen Regional Hospital; Phramongkutklao College of Medicine
1-Jan-2020Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)Young Rok Do; Jae Yong Kwak; Jeong A. Kim; Hyeoung Joon Kim; Joo Seop Chung; Ho Jin Shin; Sung Hyun Kim; Udomsak Bunworasate; Chul Won Choi; Dae Young Zang; Suk Joong Oh; Saengsuree Jootar; Ary Harryanto Reksodiputro; Won Sik Lee; Yeung Chul Mun; Jee Hyun Kong; Priscilla B. Caguioa; Hawk Kim; Jinny Park; Dong Wook Kim; Wonju Severance Christian Hospital; Keimyung University, Dongsan Medical Center; Inje University Paik Hospital; Gachon University; University of Indonesia, RSUPN Dr. Cipto Mangunkusumo; Ewha Womans University School of Medicine; Chulalongkorn University; Hallym University; Jeonbuk National University, School of Medicine; SungKyunKwan University, School of Medicine; Dong-A University; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Chonnam National University; Korea University; Pusan National University, College of Medicine; The Catholic University of Korea; St. Luke’s Medical Center
1-Feb-2018Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from ThailandTanin Intragumtornchai; Udomsak Bunworasate; Kitsada Wudhikarn; Arnuparp Lekhakula; Jakrawadi Julamanee; Kanchana Chansung; Chittima Sirijerachai; Lalita Norasetthada; Weerasak Nawarawong; Archrob Khuhapinant; Noppadol Siritanaratanakul; Tontanai Numbenjapon; Kannadit Prayongratana; Suporn Chuncharunee; Pimjai Niparuck; Tawatchai Suwanban; Nongluk Kanitsap; Somchai Wongkhantee; Rutchanid Pornvipavee; Peerapon Wong; Nisa Makruasi; Pongsak Wannakrairot; Thamathorn Assanasen; Sanya Sukpanichnant; Paisarn Boonsakan; Wasana Kanoksil; Charin Ya-in; Kanita Kayasut; Winyu Mitranun; Naree Warnnissorn; Bangkok Metropolitan Administration; Chulalongkorn University; Faculty of Medicine, Prince of Songkia University; Naresuan University; Khon Kaen University; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Faculty of Medicine, Thammasat University; Faculty of Medicine, Siriraj Hospital, Mahidol University; Phramongkutklao College of Medicine; Rajavithi Hospital; Chiang Mai University; Srinakharinwirot University; Kon Kaen Hospital
1-Feb-2020Novel DDX41 variants in Thai patients with myeloid neoplasmsChantana Polprasert; June Takeda; Pimjai Niparuck; Thanawat Rattanathammethee; Arunrat Pirunsarn; Amornchai Suksusut; Sirorat Kobbuaklee; Kitsada Wudhikarn; Panisinee Lawasut; Sunisa Kongkiatkamon; Suporn Chuncharunee; Kritanan Songserm; Prasit Phowthongkum; Udomsak Bunworasate; Yasuhito Nannya; Kenichi Yoshida; Hideki Makishima; Seishi Ogawa; Ponlapat Rojnuckarin; Institute for the Advanced Study of Human Biology; Chulalongkorn University; Mahidol University; Karolinska Institutet; Kyoto University; Chiang Mai University; Buddhasothorn Hospital
1-Dec-2017Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemiaJae Yong Kwak; Sung Hyun Kim; Suk Joong Oh; Dae Young Zang; Hawk Kim; Jeong A. Kim; Young Rok Do; Hyeoung Joon Kim; Joon Seong Park; Chul Won Choi; Won Sik Lee; Yeung Chul Mun; Jee Hyun Kong; Joo Seop Chung; Ho Jin Shin; Dae Young Kim; Jinny Park; Chul Won Jung; Udomsak Bunworasate; Narcisa Sonia Comia; Saengsuree Jootar; Arry Harryanto Reksodiputro; Priscilla B. Caguioa; Sung Eun Lee; Dong Wook Kim; Chonbuk National University, School of Medicine; Dong-A University; SungKyunKwan University, School of Medicine; Hallym University; University of Ulsan, College of Medicine; The Catholic University of Korea; Keimyung University, Dongsan Medical Center; Chonnam National University; Ajou University; Korea University; Inje University Paik Hospital; Ewha Womans University School of Medicine; Wonju Severance Christian Hospital; Pusan National University, College of Medicine; Gachon University; Chulalongkorn University; Mary Mediatrix Medical Center; Mahidol University; University of Indonesia, RSUPN Dr. Cipto Mangunkusumo; St. Luke's Medical Center Quezon City